Welcome, Guest. Please login or register.
November 23, 2017, 07:28:53 PM

Login with username, password and session length

  • Total Posts: 722728
  • Total Topics: 58738
  • Online Today: 333
  • Online Ever: 1421
  • (August 13, 2016, 05:18:44 AM)
Users Online
Users: 5
Guests: 258
Total: 263


Welcome to the POZ Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: First child 'cured' of HIV remains in remission for 18 months  (Read 1153 times)

0 Members and 1 Guest are viewing this topic.

Offline J.R.E.

  • Member
  • Posts: 7,540
  • Joined Dec-2003 Living positive, since 1985.
First child 'cured' of HIV remains in remission for 18 months
« on: October 26, 2013, 07:25:09 AM »


 Researchers have revealed that a 3-year-old girl from Mississippi who was born with HIV continues to be in remission 18 months after her combination antiretroviral treatment was stopped. This is according to an updated case report published in The New England Journal of Medicine.

Medical News Today reported on the early findings of this case in March this year, in which the researchers said was the first case of a "functional cure" in an HIV (human immunodeficiency virus) positive infant.

But the research team from the Johns Hopkins Children's Center, the University of Massachusetts Medical School and the University of Mississippi Medical Center, say this confirmation of their findings suggest that the child's remission is "not a mere fluke."

They add that the findings provide "compelling evidence" that if an HIV positive child is started on antiretroviral therapy within the first hours or days of infection, viral remission can be achieved.
Child showed 'no detectable HIV 29 days after birth'

Born to an HIV-infected mother, the child began aggressive antiretroviral therapy (ART) 30 hours after birth.

Through a series of blood tests carried out days and weeks after treatment first began, the child demonstrated rapidly diminishing levels of the virus in her blood. When tested 29 days after birth, there were no detectable traces of the viral infection.

The child received antiviral treatment until she was 18-months-old, after which point the treatment was stopped. After undergoing standard repeat HIV tests around 10 months after the ceasing of treatment, the report states that physicians detected no HIV in her blood.
Therapy 'must start early' in HIV-infected Infants

The researchers believe that through beginning the child's treatment so early, ART was able to halt the formation of hard-to-treat viral reservoirs. These are defined as immune cells with "dormant" HIV that can reignite the infection within weeks of ceasing therapy.

However, the researchers emphasize the fact that treatment in HIV-infected infants must begin very early on following infection.

They point to recent studies showing that many hard-to-eradicate viral reservoirs form in the first few weeks of an infant's life. Studies have also shown that infants with HIV show a "marked reduction" in the numbers of circulating virus-infected cells if they are treated within the first few weeks after infection.

Therefore, these findings suggest there is a small window in which a child's remission from HIV may be achieved.

Katherine Luzuriaga of the University of Massachusetts Medical School and senior author of the study, explains:

    "This case highlights the potential of prompt therapy to lead to long-term remission in those already infected by blocking the formation of the very viral reservoirs responsible for rekindling infection once treatment ceases.

    This may be particularly true in infants, whose developing immune systems may be less amenable to the formation of long-lived virus-infected immune cells."

A step towards an HIV cure

To date, the child's tests for HIV-specific antibodies and tests that detect for the presence of "killer" cells - which indicate active infection - remain negative.

However, ultrasensitive tests that are able to detect traces of the virus did find the presence of "viral footprints." But the researchers say this is a type of "leftover" HIV that seems to be unable to form new virus, meaning the infection is unlikely to reignite.

"We're thrilled that the child remains off medication and has no detectable virus replicating," says Hannah Gay, pediatrician at the University of Mississippi Medical Center. "We've continued to follow the child, obviously, and she continues to do very well. There is no sign of the return of HIV, and we will continue to follow her for the long term."

The researchers explain that because the child in this case has demonstrated absence of infection symptoms as well as lack of replicating virus, this could lead to a "sterilizing" HIV cure - a cure that has the ability to abolish all replicating virus from the body long-term.

According to the World Health Organization (WHO), at the end of 2011 there were estimated to be 3.4 million children living with HIV worldwide, with 91% of these living in sub-Saharan Africa.

WHO state that the majority of these children acquire HIV from their HIV-infected mothers during pregnancy, highlighting the need for newborn HIV treatment.

As a result of the 3-year-old's remission, a new study is set to begin early next year that will test the early antiretroviral therapy approach in order to determine whether this is a strategy that could be used for all newborns infected with HIV.
Current Meds ; Viramune, Epzicom, 20mg of Atorvastatin, 25 mg of Hydrochlorothiazide.
Amlodipine Besolate 5mg-- Updated 9/24/2017

Diagnosed positive in 1985,.. In October of 2003, My t-cell count was 16, Viral load was over 500,000, Percentage at that time was 5%. I started on  HAART on October 24th, 2003.

 As of 9/18/2017,  Viral load remains <40
CD 4 @358 /  CD4 % @ 13

 65 years young.


Terms of Membership for these forums

© 2017 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.